Furthermore, treatment of an EGFR inhibitor (PD153035) improves glucose intolerance and insulin sensitivity and reduces inflammation in diet-induced obese (DIO) mice [15], indicating the some roles of the EGFR signaling pathway in the pathophysiologies of diabetes mellitus. The gene discussed is EGFR; the disease is Glucose intolerance.